Company
Every investor coverage indicates participated in a round Harry Perkins Institute of Medical Research raised.
Companies Harry Perkins Institute of Medical Research acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Harry Perkins Institute of Medical Research. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Perth medtech spin-out Cytophenix raised a pre-seed round above its target to advance trials and grow the team behind FloCAST, a rapid test identifying effective antibiotics, after earlier grants and accelerator programs.
Roundup of eight funding deals: Synchron's Series D, plus raises by Lumonus AI, Hullbot, Nbryo, Cytophenix, Giftbee, Understanding Zoe and Zeligate, spanning medtech, robotics, agtech and AI.
Also Startup Daily·Startup Daily·Startup Daily·Startup Daily·SmartCompany·Startup Daily·Startup Daily
Western Australia's government added $15 million to its WAVC fund-of-funds, committing $45 million across seven venture firms to back local startups; Purpose Ventures' fund closed at $55 million after backing My Mirror and SpacetoCo.